167 related articles for article (PubMed ID: 37079124)
1. The validation and clinical significance of LPCAT1 down-regulation in acute myeloid leukemia.
Chen Q; Xu Z; Lin J; Deng Z; Qian J; Qian W
Mol Biol Rep; 2023 Jun; 50(6):4955-4963. PubMed ID: 37079124
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic Significance of
Liu Y; Liu YJ; Yang L; Zhang Y; Zhang DF; Jiang ZX; Wang C; Liu YF; Wang SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):64-70. PubMed ID: 36765478
[TBL] [Abstract][Full Text] [Related]
3. Identification of
Wang K; Wu Z; Si Y; Tang W; Xu X; Cheng Y; Lin J
Oncol Lett; 2021 Feb; 21(2):105. PubMed ID: 33376538
[TBL] [Abstract][Full Text] [Related]
4. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
[TBL] [Abstract][Full Text] [Related]
5. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
[TBL] [Abstract][Full Text] [Related]
7. Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics.
Tang CY; Lin J; Qian W; Yang J; Ma JC; Deng ZQ; Yang L; An C; Wen XM; Zhang YY; Qian J
Clin Chem Lab Med; 2014 Dec; 52(12):1843-50. PubMed ID: 24955525
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
Zhang P; Sun D; Sun X; Li H
Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
[TBL] [Abstract][Full Text] [Related]
9. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
Lebok P; von Hassel A; Meiners J; Hube-Magg C; Simon R; Höflmayer D; Hinsch A; Dum D; Fraune C; Göbel C; Möller K; Sauter G; Jacobsen F; Büscheck F; Prien K; Krech T; Krech RH; von der Assen A; Wölber L; Witzel I; Schmalfeldt B; Geist S; Paluchoswski P; Wilke C; Heilenkötter U; Terracciano L; Müller V; Wilczak W; Burandt EC
Aging (Albany NY); 2019 Sep; 11(18):7796-7804. PubMed ID: 31533087
[TBL] [Abstract][Full Text] [Related]
12. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
13. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Shen L; Gu P; Qiu C; Ding WT; Zhang L; Cao WY; Li ZY; Yan B; Sun X
Ann Hepatol; 2022; 27(3):100680. PubMed ID: 35108614
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia.
Zhou JD; Yang L; Zhang YY; Yang J; Wen XM; Guo H; Yao DM; Ma JC; Chen Q; Lin J; Qian J
Med Oncol; 2015 Jan; 32(1):386. PubMed ID: 25428390
[TBL] [Abstract][Full Text] [Related]
16. [Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations].
Xia PH; Xu ZJ; Jin Y; Ma JC; Wen XM; Yuan Q; Leng JY; Qian J; Lin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):659-670. PubMed ID: 35680788
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.
Wang Y; Li Y; Song HQ; Sun GW
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7364-7370. PubMed ID: 30468482
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence.
Abdelzaher E; Mostafa MF
Tumour Biol; 2015 Jul; 36(7):5473-83. PubMed ID: 25683484
[TBL] [Abstract][Full Text] [Related]
19. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
